Research & Development

Research & Development

Enzymes, proteins, optimized production strains, bioactive compounds: Our German research sites develop innovative solutions on behalf of and for our own pipeline

We offer our technologies as a contract research organization (CRO) for the benefit of our customers. Leveraging the most suitable technologies from our advanced portfolio, we deliver smart, rapid, and highly effective solutions to drive customer´s success. 

Our proven and advanced technologies & services have been successfully applied in pharmaceutical, food, feed, chemical and life science industries.

R&D operation sites

Building: Headquarter and Research Campus BRAIN Biotech in Zwingenberg, Germany
Zwingenberg, Germany: Enzyme technology, production strain and bioprocess development
The power of enzymes is that they can make, break and change a wide variety of molecules. We can use them to produce almost any molecule that we or our customers need. At the BRAIN Biotech site in Zwingenberg, Germany, our scientists have a technology portfolio for the targeted engineering of proteins and enzymes for various industries. We offer this technology portfolio to our industrial partners in the form of a flexible, modular system. In collaboration with local bioprocess engineers, we also develop and optimize bioprocesses for scale-up. Further information on the services of our technology units can be found on the BRAIN Biotech R&D website.
Read more
Old brick building in Potsdam
Potsdam, Germany: Screening & development of bioactive compounds
Scientists at BRAIN Biotech Potsdam research and develop natural products and natural substance-based active ingredients for novel pharmaceutical and cosmetic products as well as for products in the food industry. They use their own natural product libraries with fully elucidated compound structures and access to approximately 15% of all known secondary metabolites worldwide as well as thousands of previously unpublished structures. - The site was founded in 2000 and has been a subsidiary of BRAIN Biotech AG since 2013 as AnalytiCon Discovery GmbH. Since the merger in June 2024, it is an operating unit of BRAIN Biotech AG.
Read more